Retatrutide: Side effects and warnings Clinical trials show that 6 to 16% of participants stopped taking retatrutide due to side effects, mostly gastrointestinal symptoms that tend to improve as your body adjusts
Knowing how to tell if a vial of semaglutide has gone bad is essential for anyone using this medication
Other companies are working on their own weight-loss pills: Eli Lilly, which makes Zepbound, is developing a GLP-1 pill, orforglipron, for weight loss and type 2 diabetes, with FDA approval anticipated for March 2026
So, if youve been wondering whether fasting and GLP-1 supplements can actually work together for weight loss, youre in for a treat
Unlike more potent acids, these two are non-irritating and safe for daily use